1. U.S. Government Printing Office. Code of Federal Regulations Title 21—Food and Drugs. Part 320—Bioavailability and Bioequivalence Requirements. http://www.access.gpo.gov/nara/cfr/waisidx_03/21cfr320_03.html (accessed February 9, 2008).
2. CDER/FDA. Draft Guidance for Industry, Bioequivalence Recommendations for Specific Products. May 2007. http://www.fda.gov/cder/guidance/6772dft.pdf (accessed February 9, 2008).
3. OGD/CDER/FDA. Individual Product Bioequivalence Recommendations. http://www.fda.gov/cder/guidance/bioequivalence/#Ind_Rec (accessed February 9, 2008).
4. CDER/FDA. Guidance for Industry, Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General Considerations. March 2003. http://www.fda.gov/cder/guidance/5356fnl.pdf (accessed February 9, 2008).
5. D.G. Safran, P. Neuman, C. Schoen, M.S. Kitchman, I.B. Wilson, B. Cooper, A. Li, H. Chang, and W.H. Rogers. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff. 10.1377/hlthaff.w5.152 (2005).